RECENT DEALS
RECENT DEALS
|
TOOLBOX
   Resize
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
Who's Blogging  |
MERGERS AND ACQUISITIONS
ICF Consulting Group Inc ., a Fairfax consulting firm, announced that it has acquired Caliber
Associates Inc ., a Fairfax firm that offers high-end consulting services, primarily to U.S. federal clients. Terms of the transaction were not disclosed. Branch Banking and Trust Co . advised Caliber on the transaction. Legg Mason Inc . advised ICF.
PUBLIC OFFERINGS
First Potomac Realty Trust of Bethesda said it will sell 3 million shares for $24.23 each to net about $68.9 million, in a follow-on offering. The company plans to use the proceeds to pay down the balance on its revolving line of credit. The offering was managed by KeyBanc
Capital Markets.
PRIVATE EQUITY
VidSys Inc. , an Alexandria video communications software firm, sold $6.75 million worth of Series A preferred stock to three investors, according to a Securities and Exchange Commission filing. The money is to be used for working capital. Investors include IDG Ventures
Atlantic of Boston and DTS Video Holdings of Alexandria.
AirOcare Inc. , a Rockville maker of air-purifying equipment, sold $2.8 million in Series A preferred stock to 22 investors, according to an SEC filing. The money is to be used for working capital.
A&G Pharmaceutical Inc. , a Columbia drug research and development firm, sold $2 million in Series A preferred stock to seven investors, according to an SEC filing. About half will go toward repayment of debt, the rest for working capital. Investors include New England
Partners Capital LP of Boston, MedImmune Inc. of Gaithersburg, and the Maryland Department of
